|
Intervention with early survival benefit, questionable long term harm
|
|
7
|
94
|
May 25, 2022
|
|
Schoenfeld Residuals
|
|
1
|
60
|
May 23, 2022
|
|
Comparing non-nested models on the same data
|
|
4
|
222
|
May 13, 2022
|
|
Should I impute person-time before conducting proportional hazards analysis?
|
|
7
|
142
|
May 8, 2022
|
|
Background to PFS endpoint
|
|
16
|
802
|
May 8, 2022
|
|
Stratification on a variable involved in an interaction term
|
|
3
|
209
|
May 4, 2022
|
|
Validation of cox model
|
|
4
|
1669
|
May 2, 2022
|
|
Cutpoint for Estimation of Prognostic value of a continuous Marker
|
|
5
|
373
|
May 2, 2022
|
|
How should I compare crossing survival curves?
|
|
5
|
281
|
April 28, 2022
|
|
Is logistic regression or survival analysis most appropriate in this case?
|
|
1
|
150
|
April 28, 2022
|
|
Statistical power estimation for a time-dependent covariate in Cox (proportional hazards) regression
|
|
0
|
143
|
April 19, 2022
|
|
Propensity score weighting and competing risks
|
|
2
|
323
|
March 30, 2022
|
|
How to calculate number of events in each treatment arm given hazard ratio and CI?
|
|
2
|
520
|
March 6, 2022
|
|
RMS Case Study in Cox Regression
|
|
1
|
4733
|
September 17, 2021
|
|
Hazard ratio plots with non-linear & time-varying effects in R
|
|
28
|
23637
|
September 19, 2020
|
|
How to use RCS in mixed effects cox regression
|
|
3
|
954
|
December 10, 2021
|
|
Kaplan-Meier: SE for absolute difference in time-point survival
|
|
13
|
1172
|
October 30, 2021
|
|
How can I determined the best cutoff for survival ROC
|
|
1
|
1001
|
October 10, 2021
|
|
First RCT of Lopinavir–Ritonavir on SARS-CoV2
|
|
38
|
11447
|
October 8, 2021
|
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
2
|
2855
|
September 22, 2021
|
|
RMS Case Study in Parametric Survival Modeling
|
|
0
|
3814
|
September 17, 2021
|
|
What is the best way to establish correlation between two time-to-event analysis?
|
|
6
|
1465
|
September 13, 2021
|
|
How to handle MNAR from a covariate due to witnessing the survival outcome?
|
|
2
|
946
|
September 10, 2021
|
|
Cox regression vs. competing risk regression?
|
|
9
|
1841
|
August 23, 2021
|
|
Probability in state Ps(t) and Hazard ratio HR in Cox model
|
|
1
|
1115
|
August 21, 2021
|
|
Restricted mean survival time and comparing treatments under non-proportional hazards
|
|
6
|
3217
|
August 10, 2021
|
|
Meta-analysis of time-to-event data for single group design
|
|
5
|
1451
|
June 17, 2021
|
|
Calculation of Sample Size for Survival: Logrank vs. Cox with covariates
|
|
2
|
1242
|
June 17, 2021
|
|
Inherent problems of cluster analysis
|
|
17
|
2460
|
May 27, 2021
|
|
Cox regression: HR calculation by hand
|
|
8
|
1585
|
May 6, 2021
|